Alterity Therapeutics (PRNAD) Gains from Investment Securities (2009 - 2019)
Alterity Therapeutics (PRNAD) posted quarterly Gains from Investment Securities of $49858.4 for Q4 2019, down 95.17% on a QoQ basis from $1.0 million in Q4 2015.
Alterity Therapeutics (PRNAD) Gains from Investment Securities (2009 - 2019) Analysis & Trends
Alterity Therapeutics (PRNAD) has reported Gains from Investment Securities for 6 consecutive years, with $49858.4 the latest figure, recorded in Q4 2019.
- In Q4 2019, Gains from Investment Securities changed N/A year-over-year to $49858.4; the TTM figure through Dec 2019 stood at -$47.3 billion (changed N/A YoY), while the FY2024 annual figure was -$58023.0, changed N/A from the prior year.
- Gains from Investment Securities came in at $49858.4 for Q4 2019 at Alterity Therapeutics, down from $1.0 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $1.0 million in Q4 2015, with the low at $49858.4 in Q4 2019.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 49,858.44 |
| Dec 31, 2019 | 49,858.44 |
| Dec 31, 2015 | 1.03 Mn |
| Dec 31, 2015 | 1.03 Mn |
| Jun 30, 2012 | -47.29 Bn |
| Jun 30, 2012 | -47.29 Bn |
| Dec 31, 2011 | -5,666.94 |
| Dec 31, 2011 | -5,666.94 |
| Jun 30, 2011 | 158.76 Bn |
| Jun 30, 2011 | 158.76 Bn |
| Dec 31, 2010 | 176,193.00 |
| Dec 31, 2010 | 176,193.00 |
| Jun 30, 2010 | 2,017.00 |
| Jun 30, 2010 | 2,017.00 |
| Dec 31, 2009 | -26,785.00 |
| Dec 31, 2009 | -26,785.00 |
| Jun 30, 2009 | -15,501.00 |
| Jun 30, 2009 | -15,501.00 |